AAAAAA

   
Results: 1-12 |
Results: 12
A PHASE I II EVALUATION OF ORAL L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACIDIN ASYMPTOMATIC PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/
Authors: BARDITCHCROVO P NOE D SKOWRON G LEDERMAN M KALAYJIAN RC BORUM P BUIER R ROWE WB GOLDBERG D LIETMAN P
Citation: P. Barditchcrovo et al., A PHASE I II EVALUATION OF ORAL L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACIDIN ASYMPTOMATIC PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, Journal of clinical pharmacology, 38(4), 1998, pp. 357-363
SAFETY, PHARMACOKINETICS, AND ANTIRETROVIRAL ACTIVITY OF INTRAVENOUS 9-[2-(R)-(PHOSPHONOMETHOXY)PROPYL]ADENINE A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS
Authors: DEEKS SG BARDITCHCROVO P LIETMAN PS HWANG F CUNDY KC ROONEY JF HELLMANN NS SAFRIN S KAHN JO
Citation: Sg. Deeks et al., SAFETY, PHARMACOKINETICS, AND ANTIRETROVIRAL ACTIVITY OF INTRAVENOUS 9-[2-(R)-(PHOSPHONOMETHOXY)PROPYL]ADENINE A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2380-2384
A PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE EFFECT OF RIFAMPIN AND RIFABUTIN ON COMBINATION ORAL-CONTRACEPTIVES
Authors: BARDITCHCROVO P TRAPNELL CB ETTE E ZACUR H FLEXNER C
Citation: P. Barditchcrovo et al., A PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF THE EFFECT OF RIFAMPIN AND RIFABUTIN ON COMBINATION ORAL-CONTRACEPTIVES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 31-31
QUANTIFICATION OF LATENT TISSUE RESERVOIRS AND TOTAL-BODY VIRAL LOAD IN HIV-1 INFECTION
Authors: CHUN TW CARRUTH L FINZI D SHEN XF DIGIUSEPPE JA TAYLOR H HERMANKOVA M CHADWICK K MARGOLICK J QUINN TC KUO YH BROOKMEYER R ZEIGER MA BARDITCHCROVO P SILICIANO RF
Citation: Tw. Chun et al., QUANTIFICATION OF LATENT TISSUE RESERVOIRS AND TOTAL-BODY VIRAL LOAD IN HIV-1 INFECTION, Nature, 387(6629), 1997, pp. 183-188
ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY, SAFETY, AND PHARMACOKINETICS OF ADEFOVIR DIPIVOXIL PIVALOYLOXYMETHYL)-PHOSPHONYLMETHOXYETHYL]ADENINE) IN HIV-INFECTED PATIENTS
Authors: BARDITCHCROVO P TOOLE J HENDRIX CW CUNDY KC EBELING D JAFFE HS LIETMAN PS
Citation: P. Barditchcrovo et al., ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) ACTIVITY, SAFETY, AND PHARMACOKINETICS OF ADEFOVIR DIPIVOXIL PIVALOYLOXYMETHYL)-PHOSPHONYLMETHOXYETHYL]ADENINE) IN HIV-INFECTED PATIENTS, The Journal of infectious diseases, 176(2), 1997, pp. 406-413
QUANTITATION OF VAGINALLY ADMINISTERED NONOXYNOL-9 IN PREMENOPAUSAL WOMEN
Authors: BARDITCHCROVO P WITTER F HAMZEH F MCPHERSON J STRATTON P ALEXANDER NJ TRAPNELL CB
Citation: P. Barditchcrovo et al., QUANTITATION OF VAGINALLY ADMINISTERED NONOXYNOL-9 IN PREMENOPAUSAL WOMEN, Contraception, 55(4), 1997, pp. 261-263
DETERMINATION OF THE SPERMICIDE NONOXYNOL-9 IN VAGINAL LAVAGE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
Authors: MCPHERSON JL NICHOLS JH BARDITCHCROVO P HAMZEH FM
Citation: Jl. Mcpherson et al., DETERMINATION OF THE SPERMICIDE NONOXYNOL-9 IN VAGINAL LAVAGE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 677(1), 1996, pp. 204-208
SCREENING FOR BETA-OXIDATION ABNORMALITIES AS AN INDICATOR OF DRUG-INDUCED IMPAIRED MITOCHONDRIAL-FUNCTION IN PEOPLE RECEIVING ZIDOVUDINE (ZDV)
Authors: WACHSMAN M BARDITCHCROVO P PETTY BG TRAPNELL CB BRUSILOW S LIETMAN PS
Citation: M. Wachsman et al., SCREENING FOR BETA-OXIDATION ABNORMALITIES AS AN INDICATOR OF DRUG-INDUCED IMPAIRED MITOCHONDRIAL-FUNCTION IN PEOPLE RECEIVING ZIDOVUDINE (ZDV), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 50-50
QUANTITATION OF VAGINALLY ADMINISTERED NONOXYNOL-9 (N9) IN PREMENOPAUSAL WOMEN
Authors: BARDITCHCROVO P WITTER F HAMZEH F MCPHERSON J STRATTON P ALEXANDER N TRAPNELL CB HOPKINS J
Citation: P. Barditchcrovo et al., QUANTITATION OF VAGINALLY ADMINISTERED NONOXYNOL-9 (N9) IN PREMENOPAUSAL WOMEN, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 97-97
LACK OF BETA-OXIDATION DEFECTS IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS WITH AND WITHOUT CHRONIC ZIDOVUDINE EXPOSURE
Authors: WACHSMAN M BARDITCHCROVO P LIETMAN PS TRAPNELL CB
Citation: M. Wachsman et al., LACK OF BETA-OXIDATION DEFECTS IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS WITH AND WITHOUT CHRONIC ZIDOVUDINE EXPOSURE, Blood, 88(8), 1996, pp. 3243-3244
APPARENT DEFICIENCY OF GLUTATHIONINE IN THE PBMCS OF PEOPLE WITH AIDSDEPENDS ON METHOD OF EXPRESSION
Authors: BARDITCHCROVO P SVOBODOVA V LIETMAN P
Citation: P. Barditchcrovo et al., APPARENT DEFICIENCY OF GLUTATHIONINE IN THE PBMCS OF PEOPLE WITH AIDSDEPENDS ON METHOD OF EXPRESSION, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 313-314
CLINICAL PHARMACOKINETICS OF ADEFOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUSTYPE 1-INFECTED PATIENTS
Authors: CUNDY KC BARDITCHCROVO P WALKER RE COLLIER AC EBELING D TOOLE J JAFFE HS
Citation: Kc. Cundy et al., CLINICAL PHARMACOKINETICS OF ADEFOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUSTYPE 1-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 39(11), 1995, pp. 2401-2405
Risultati: 1-12 |